Syracuse University   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Syracuse NY United States (1831)

Organization Overview

First Clinical Trial
2013
NCT01864525
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Syracuse University

Active Ingredients

Drugs in Phase 2 Trials (1)

octanoic acid (1 trial)

Drugs in Phase 1 Trials (1)

ethanol (1 trial)

Drugs in Other Trials (2)

iron (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcohol Drinking (Phase 1)

Essential Tremor (Phase 2)

Tremor (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4